financetom
Business
financetom
/
Business
/
Edwards Lifesciences misses Q2 revenue estimates on weak demand for heart devices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Edwards Lifesciences misses Q2 revenue estimates on weak demand for heart devices
Jul 24, 2024 3:10 PM

July 24 (Reuters) - Edwards Lifesciences ( EW ) missed

second-quarter revenue estimates on Thursday, hurt by

lower-than-expected demand for its artificial heart valves.

Shares of the California-based company were down 14.3% at

$74.50 after the bell.

Edwards reported revenue of $1.39 billion, falling short of

analysts' estimates of $1.65 billion, according to LSEG data.

Investor expectations for medical device makers have been

high in recent quarters, driven by sustained demand for surgical

procedures, especially among older adults.

Separately, Edwards, which sold its critical care products

unit to Becton Dickinson ( BDX ) last month, said it will

acquire heart device makers JenaValve Technology and Endotronix

to expand its structural heart portfolio.

The deals, valued at approximately $1.2 billion, further

solidify Edwards' transition to becoming a pure-play structural

heart company, with its lead product being the transcatheter

aortic valve replacement (TAVR) device, which is used for

minimally invasive heart surgeries.

Sales from the TAVR unit rose 5% to $1.0 billion in the

quarter ended June 30, compared to estimates of $1.06 billion.

However, the company revised the sales forecast for TAVR

devices for the second half of the year to a 5% to 7% increase,

down from the previous guidance of 8% to 10%.

The company forecast third-quarter sales to be between $1.56

to $1.64 billion, assuming critical care is included for the

entire third quarter.

On an adjusted basis, the company reported a second-quarter

profit of 70 cents per share, narrowly beating analysts'

estimates of 69 cents per share.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lattice Semiconductor Reports Q1 Results, Guides Q2 Revenue Below Estimates
Lattice Semiconductor Reports Q1 Results, Guides Q2 Revenue Below Estimates
Apr 29, 2024
Lattice Semiconductor Corporation ( LSCC ) reported its first-quarter financial results after the bell Monday. Here's a look at the details. The Details: Lattice Semiconductor ( LSCC ) reported quarterly earnings of 29 cents per share which beat the analyst consensus estimate of 28 cents and is a 43.14% decrease from earnings of 51 cents per share from the same...
Old National Bancorp Insider Sold Shares Worth $803,825, According to a Recent SEC Filing
Old National Bancorp Insider Sold Shares Worth $803,825, According to a Recent SEC Filing
Apr 29, 2024
04:27 PM EDT, 04/29/2024 (MT Newswires) -- Brendon B Falconer, CFO, on April 25, 2024, sold 49,375 shares in Old National Bancorp ( ONB ) for $803,825. Following the Form 4 filing with the SEC, Falconer has control over a total of 88,712 shares of the company, with 88,712 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/707179/000112760224013559/xslF345X03/form4.xml ...
Gibson Energy Posts Q1 Net Income Drop Despite Higher Revenues
Gibson Energy Posts Q1 Net Income Drop Despite Higher Revenues
Apr 29, 2024
04:29 PM EDT, 04/29/2024 (MT Newswires) -- Gibson Energy ( GBNXF ) after trade Monday reported a first-quarter net income miss, despite higher revenues. The oil infrastructure and marketing company reported net income of C$40 million in the first quarter, a C$48 million or 54% decrease over the first quarter of 2023 and compared to a Capital IQ forecast of...
BRIEF-Hologic To Acquire Endomagnetics Ltd, A Breast Surgical Guidance Company
BRIEF-Hologic To Acquire Endomagnetics Ltd, A Breast Surgical Guidance Company
Apr 29, 2024
April 29 (Reuters) - Hologic Inc ( HOLX ): * HOLOGIC TO ACQUIRE ENDOMAGNETICS LTD, A BREAST SURGICAL GUIDANCE COMPANY * HOLOGIC INC ( HOLX ) - PROPOSED DEAL FOR FOR APPROXIMATELY $310 MILLION * HOLOGIC ( HOLX )- DEAL EXPECTED TO BE SLIGHTLY DILUTIVE TO HOLOGIC'S NON-GAAP EARNINGS PER SHARE IN FISCAL 2024, BREAK EVEN IN 2025 AND ACCRETIVE...
Copyright 2023-2025 - www.financetom.com All Rights Reserved